Condition

Carcinoma, Non-Small-Cell Lung (2)

Adenocarcinoma of the Gastroesophageal Junction (1)

Alzheimer's Disease (1)

Gastric Adenocarcinoma (1)

Gastric Cancer (1)

Mild Cognitive Impairment (1)

Overall Status

Terminated (2)

Active, not recruiting (1)

Completed (1)

Phase

n/a (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Alliance for Clinical Trials in Oncology (1)

National Cancer Institute (NCI) (1)

University of Michigan Rogel Cancer Center (1)

University of Pennsylvania (1)

Collaborator

National Cancer Institute (NCI) (1)

National Institute on Aging (NIA) (1)

Study Documents

Intervention Type

drug (4)

procedure (2)

radiation (2)

device (1)

dietary supplement (1)

other (1)

Funder Type

Other (3)

NIH (1)

Study Type

Interventional (3)

Observational (1)

fdg-pet

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

NSCLC Trial in Ann Arbor (radiation, drug, device)

Active, not recruiting

Carcinoma, Non-Small-Cell Lung

Response-driven Adaptive Radiation Therapy
+5 more

Ann Arbor, Michigan
+1 more

Dec 17, 2021

Arterial Spin Labeling (ASL) MRI for Cognitive Decline

Completed

Mild Cognitive Impairment
Alzheimer's Disease

FDG-PET
+2 more

Philadelphia, Pennsylvania

Penn Memory Center

Sep 25, 2020

NSCLC Trial run by the NCI (FDG-PET, Pemetrexed, Sirolimus)

Terminated

Has Results

Carcinoma, Non-Small-Cell Lung

FDG-PET
+5 more

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Nov 15, 2019

Adenocarcinoma of the Gastroesophageal Junction, Gastric Adenocarcinoma, Gastric Cancer Trial in United States (procedure, drug,

Terminated

Has Results

Adenocarcinoma of the Gastroesophageal Junction
+2 more

FDG-PET
+7 more

Los Angeles, California
+70 more

Sep 10, 2019